Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting

ABSTRACT Introduction and objectives: The results of Magmaris implantation in the acute coronary syndrome setting is uncertain and more studies will be needed to assess the long-term safety profile of these devices. The objective of this work was to conduct an observational study to analyze the clin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeremías Bayón, Verónica Gordo, Melisa Santás-Álvarez, Rosa-Alba Abellás-Sequeiros, Raymundo Ocaranza-Sánchez, Carlos González-Juanatey
Formato:	article
Lenguaje:	EN ES
Publicado:	Permanyer 2021
Materias:	Magmaris Acute coronary syndrome Bioresorbable scaffold thrombosis Medicine R
Acceso en línea:	https://doaj.org/article/34463a69de924d769b6a78af1880dddf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:34463a69de924d769b6a78af1880dddf
record_format	dspace
spelling	oai:doaj.org-article:34463a69de924d769b6a78af1880dddf2021-11-16T10:21:07ZLong-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting10.24875/RECICE.M210002162604-7322https://doaj.org/article/34463a69de924d769b6a78af1880dddf2021-11-01T00:00:00Zhttps://recintervcardiol.org/en/index.php?option=com_content&view=article&id=679https://doaj.org/toc/2604-7322ABSTRACT Introduction and objectives: The results of Magmaris implantation in the acute coronary syndrome setting is uncertain and more studies will be needed to assess the long-term safety profile of these devices. The objective of this work was to conduct an observational study to analyze the clinical safety profile of Magmaris implanted in a single hospital center in the acute coronary syndrome setting beyond 12 months. Methods: Registry of 36 patients with Magmaris devices implanted between November 2016 through November 2018 with a diagnosis of acute coronary syndrome included consecutively. The primary endpoint was considered the device-oriented composite endpoint of target vessel myocardial infarction, target lesion failure, and cardiac death. Secondary endpoints included Magmaris related thrombosis. Results: Regarding the device-oriented combination, no target vessel myocardial infarction was observed, 0 cases (0%), while target lesion failure was seen in 2 cases (5.6%). There were no cases of Magmaris thrombosis at the follow-up and only 1 case of cardiac death (2.8%) was found 36 months after Magmaris implantation. The cause of death could not be determined since no autopsy was performed. Conclusions: Our results with long-term follow-up confirm that Magmaris has a favorable clinical profile in the acute coronary syndrome complex setting.Jeremías BayónVerónica GordoMelisa Santás-ÁlvarezRosa-Alba Abellás-SequeirosRaymundo Ocaranza-SánchezCarlos González-JuanateyPermanyerarticleMagmaris Acute coronary syndrome Bioresorbable scaffold thrombosisMedicineRENESREC: Interventional Cardiology (English Ed.), Vol 3, Iss 4, Pp 274-277 (2021)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	Magmaris Acute coronary syndrome Bioresorbable scaffold thrombosis Medicine R
spellingShingle	Magmaris Acute coronary syndrome Bioresorbable scaffold thrombosis Medicine R Jeremías Bayón Verónica Gordo Melisa Santás-Álvarez Rosa-Alba Abellás-Sequeiros Raymundo Ocaranza-Sánchez Carlos González-Juanatey Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
description	ABSTRACT Introduction and objectives: The results of Magmaris implantation in the acute coronary syndrome setting is uncertain and more studies will be needed to assess the long-term safety profile of these devices. The objective of this work was to conduct an observational study to analyze the clinical safety profile of Magmaris implanted in a single hospital center in the acute coronary syndrome setting beyond 12 months. Methods: Registry of 36 patients with Magmaris devices implanted between November 2016 through November 2018 with a diagnosis of acute coronary syndrome included consecutively. The primary endpoint was considered the device-oriented composite endpoint of target vessel myocardial infarction, target lesion failure, and cardiac death. Secondary endpoints included Magmaris related thrombosis. Results: Regarding the device-oriented combination, no target vessel myocardial infarction was observed, 0 cases (0%), while target lesion failure was seen in 2 cases (5.6%). There were no cases of Magmaris thrombosis at the follow-up and only 1 case of cardiac death (2.8%) was found 36 months after Magmaris implantation. The cause of death could not be determined since no autopsy was performed. Conclusions: Our results with long-term follow-up confirm that Magmaris has a favorable clinical profile in the acute coronary syndrome complex setting.
format	article
author	Jeremías Bayón Verónica Gordo Melisa Santás-Álvarez Rosa-Alba Abellás-Sequeiros Raymundo Ocaranza-Sánchez Carlos González-Juanatey
author_facet	Jeremías Bayón Verónica Gordo Melisa Santás-Álvarez Rosa-Alba Abellás-Sequeiros Raymundo Ocaranza-Sánchez Carlos González-Juanatey
author_sort	Jeremías Bayón
title	Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
title_short	Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
title_full	Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
title_fullStr	Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
title_full_unstemmed	Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
title_sort	long-term (> 12 months) single-center registry of magmaris implantation in the acute coronary syndrome setting
publisher	Permanyer
publishDate	2021
url	https://doaj.org/article/34463a69de924d769b6a78af1880dddf
work_keys_str_mv	AT jeremiasbayon longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting AT veronicagordo longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting AT melisasantasalvarez longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting AT rosaalbaabellassequeiros longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting AT raymundoocaranzasanchez longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting AT carlosgonzalezjuanatey longterm12monthssinglecenterregistryofmagmarisimplantationintheacutecoronarysyndromesetting
_version_	1718426535995637760

Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting

Ejemplares similares